Orion Oyj (BIT:1ORNBV)
Italy · Delayed Price · Currency is EUR 68.80
+3.25 (4.96%)
At close: Oct 10, 2025
Revenue by Product
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2010 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2010 - 2019 |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Sale of Goods | 1.14B | Log In | Log In | Log In | Log In | Upgrade |
Sale of Goods Growth | 12.53% | Log In | Log In | Log In | Log In | Upgrade |
Royalty Income | 271.00M | Log In | Log In | Log In | Log In | Upgrade |
Royalty Income Growth | 120.82% | Log In | Log In | Log In | Log In | Upgrade |
Milestone Payments | 133.80M | Log In | Log In | Log In | Log In | Upgrade |
Milestone Payments Growth | 285.47% | Log In | Log In | Log In | Log In | Upgrade |
Animal Health | 128.20M | Log In | Log In | Log In | Log In | Upgrade |
Animal Health Growth | 19.74% | Log In | Log In | Log In | Log In | Upgrade |
Fermion | 72.30M | Log In | Log In | Log In | Log In | Upgrade |
Fermion Growth | -12.83% | Log In | Log In | Log In | Log In | Upgrade |
Translation Differences and Other Operations | 800.00K | Log In | Log In | Log In | Log In | Upgrade |
Translation Differences and Other Operations Growth | -250.00% | Log In | Log In | Log In | Log In | Upgrade |
Innovative Medicines | 525.20M | Log In | Log In | Log In | Log In | Upgrade |
Innovative Medicines Growth | 127.05% | Log In | Log In | Log In | Log In | Upgrade |
Branded Products | 287.50M | Log In | Log In | Log In | Log In | Upgrade |
Branded Products Growth | 10.32% | Log In | Log In | Log In | Log In | Upgrade |
Generics and Consumer Health | 528.40M | Log In | Log In | Log In | Log In | Upgrade |
Generics and Consumer Health Growth | 4.55% | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2010 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2010 - 2019 |
Finland | 347.40M | Log In | Log In | Log In | Log In | Upgrade |
Finland Growth | 6.26% | Log In | Log In | Log In | Log In | Upgrade |
Scandinavia | 163.10M | Log In | Log In | Log In | Log In | Upgrade |
Scandinavia Growth | 13.77% | Log In | Log In | Log In | Log In | Upgrade |
Other Europe | 431.30M | Log In | Log In | Log In | Log In | Upgrade |
Other Europe Growth | 24.99% | Log In | Log In | Log In | Log In | Upgrade |
North America | 368.70M | Log In | Log In | Log In | Log In | Upgrade |
North America Growth | 116.76% | Log In | Log In | Log In | Log In | Upgrade |
Other Markets | 231.90M | Log In | Log In | Log In | Log In | Upgrade |
Other Markets Growth | 27.63% | Log In | Log In | Log In | Log In | Upgrade |
Other
Financials in millions EUR. Fiscal year is January - December.
Millions EUR. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2010 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2010 - 2019 |
Human Pharmaceuticals (Hospital and Pharmacy Channel) Reported Market Share | - | Log In | Log In | Log In | Log In | Upgrade |
Reference Priced Prescription Drugs (Pharmacy Channel) Reported Market Share | - | Log In | Log In | Log In | Log In | Upgrade |
Self-Care Products (Pharmacy Channel) Reported Market Share | - | Log In | Log In | Log In | Log In | Upgrade |
Prescription Drugs (Pharmacy Channel) Reported Market Share | - | Log In | Log In | Log In | Log In | Upgrade |